{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T21:25:39Z","timestamp":1783286739184,"version":"3.54.6"},"reference-count":39,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.3892\/mco.2017.1226","type":"journal-article","created":{"date-parts":[[2017,4,21]],"date-time":"2017-04-21T11:55:21Z","timestamp":1492775721000},"page":"886-892","source":"Crossref","is-referenced-by-count":11,"title":["Salivary duct carcinoma treated with cetuximab-based targeted therapy: A case report"],"prefix":"10.3892","volume":"6","author":[{"given":"Kenta","family":"Kawahara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akimitsu","family":"Hiraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoji","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetaka","family":"Arita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kan-Ichi","family":"Koga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyuki","family":"Hirosue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiki","family":"Fukuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2017,4,21]]},"reference":[{"key":"key20180107152345_b1-mco-0-0-1226","first-page":"454","article-title":"Salivary duct carcinoma of the parotid gland. Cytologic and histopathologic study","volume":"29","author":"Gal","year":"1985","journal-title":"Acta Cytol"},{"key":"key20180107152345_b2-mco-0-0-1226","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1002\/cncr.21116","article-title":"Clinical and immunohistologic typing of salivary duct carcinoma: A report of 50 cases","volume":"103","author":"Jaehne","year":"2005","journal-title":"Cancer"},{"key":"key20180107152345_b3-mco-0-0-1226","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-84506-2","article-title":"World Health Organization","volume-title":"Histological typing of salivary gland tumors","author":"Seifert","year":"1991","edition":"2nd"},{"key":"key20180107152345_b4-mco-0-0-1226","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/978-3-662-12814-5_8","volume-title":"Progress in surgical pathology","author":"Seifert","year":"1989"},{"key":"key20180107152345_b5-mco-0-0-1226","first-page":"236","volume-title":"Pathology and genetics of head and neck tumours","author":"Barnes","year":"2005"},{"key":"key20180107152345_b6-mco-0-0-1226","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.5858\/133.11.1763","article-title":"Update on selected salivary gland neoplasms","volume":"133","author":"McHugh","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"key20180107152345_b7-mco-0-0-1226","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/jrr\/rrt026","article-title":"Postoperative radiotherapy in patients with salivary duct carcinoma: Clinical outcomes and prognostic factors","volume":"54","author":"Shinoto","year":"2013","journal-title":"J Radiat Res"},{"key":"key20180107152345_b8-mco-0-0-1226","doi-asserted-by":"crossref","first-page":"e947","DOI":"10.1259\/bjr\/21574486","article-title":"Treatment results of post-operative radiotherapy in patients with salivary duct carcinoma of the major salivary glands","volume":"85","author":"Kim","year":"2012","journal-title":"Br J Radiol"},{"key":"key20180107152345_b9-mco-0-0-1226","doi-asserted-by":"crossref","first-page":"E820","DOI":"10.1002\/hed.24107","article-title":"Salivary duct carcinoma: Treatment, outcomes, and patterns of failure","volume":"8","author":"Johnston","year":"2016","journal-title":"Head Neck"},{"key":"key20180107152345_b10-mco-0-0-1226","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00405-012-1997-4","article-title":"Management and outcome of salivary duct carcinoma in major salivary glands","volume":"270","author":"Salovaara","year":"2013","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"key20180107152345_b11-mco-0-0-1226","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00234-012-1014-z","article-title":"Salivary duct carcinomas: Clinical and CT and MR imaging features in 20 patients","volume":"54","author":"Weon","year":"2012","journal-title":"Neuroradiology"},{"key":"key20180107152345_b12-mco-0-0-1226","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/jso.21045","article-title":"Prognostic values of pathologic findings and hypoxia markers in 21 patients with salivary duct carcinoma","volume":"97","author":"Roh","year":"2008","journal-title":"J Surg Oncol"},{"key":"key20180107152345_b13-mco-0-0-1226","doi-asserted-by":"crossref","first-page":"E25","DOI":"10.1002\/hed.23429","article-title":"Human epidermal receptor 2-amplified salivary duct carcinoma: Regression with dual human epidermal receptor 2 inhibition and anti-vascular endothelial growth factor combination treatment","volume":"36","author":"Falchook","year":"2014","journal-title":"Head Neck"},{"key":"key20180107152345_b14-mco-0-0-1226","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3892\/ol.2014.2655","article-title":"Salivary duct carcinoma of the parotid gland: A case report and review of the literature","volume":"9","author":"Xie","year":"2015","journal-title":"Oncol Lett"},{"key":"key20180107152345_b15-mco-0-0-1226","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.joms.2013.11.014","article-title":"Salivary duct carcinoma of the parotid gland: Is adjuvant HER-2-targeted therapy required?","volume":"72","author":"Lee","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"key20180107152345_b16-mco-0-0-1226","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1634\/theoncologist.2012-0369","article-title":"Trastuzumab for the treatment of salivary duct carcinoma","volume":"18","author":"Limaye","year":"2013","journal-title":"Oncologist"},{"key":"key20180107152345_b17-mco-0-0-1226","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1001\/archotol.127.9.1075","article-title":"Expression of androgen receptor, epidermal growth factor receptor, and transforming growth factor alpha in salivary duct carcinoma","volume":"127","author":"Fan","year":"2001","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"key20180107152345_b18-mco-0-0-1226","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/PAS.0b013e3180caa099","article-title":"Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: Biologic significance and potential role in therapeutic stratification of patients","volume":"31","author":"Williams","year":"2007","journal-title":"Am J Surg Path"},{"key":"key20180107152345_b19-mco-0-0-1226","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1158\/1078-0432.CCR-09-0238","article-title":"Genetic and expression analysis of HER-2 and EGFR genes in salivary duct carcinoma: Empirical and therapeutic significance","volume":"16","author":"Williams","year":"2010","journal-title":"Clin Cancer Res"},{"key":"key20180107152345_b20-mco-0-0-1226","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.oraloncology.2008.07.010","article-title":"Cetuximab in recurrent and\/or metastatic salivary gland carcinomas: A phase II study","volume":"45","author":"Locati","year":"2009","journal-title":"Oral Oncol"},{"key":"key20180107152345_b21-mco-0-0-1226","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0344-0338(11)80220-7","article-title":"WHO International histological classification of tumours. Tentative histological classification of salivary gland tumours","volume":"186","author":"Seifert","year":"1990","journal-title":"Pathol Res Pract"},{"key":"key20180107152345_b22-mco-0-0-1226","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJMoa0802656","article-title":"Platinum-based chemotherapy plus cetuximab in head and neck cancer","volume":"359","author":"Vermorken","year":"2008","journal-title":"New Engl J Med"},{"key":"key20180107152345_b23-mco-0-0-1226","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/hed.23707","article-title":"Platinum-based chemotherapy plus cetuximab first-line for Asian patients with recurrent and\/or metastatic squamous cell carcinoma of the head and neck: Results of an open-label, single-arm, multicenter trial","volume":"37","author":"Guo","year":"2015","journal-title":"Head Neck"},{"key":"key20180107152345_b24-mco-0-0-1226","doi-asserted-by":"crossref","first-page":"e0116965","DOI":"10.1371\/journal.pone.0116965","article-title":"Randomized phase III trial of adjuvant chemotherapy with S-1 after curative treatment in patients with squamous-cell carcinoma of the head and neck (ACTS-HNC)","volume":"10","author":"Tsukahara","year":"2015","journal-title":"PLoS One"},{"key":"key20180107152345_b25-mco-0-0-1226","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/BF00301495","article-title":"Salivary duct carcinoma. A group of salivary gland tumors analogous to mammary duct carcinoma","volume":"192","author":"Kleinsasser","year":"1968","journal-title":"Arch Klin Exp Ohren Nasen Kehlkopfheilkd"},{"key":"key20180107152345_b26-mco-0-0-1226","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.semradonc.2012.03.009","article-title":"Biology and management of salivary gland cancers","volume":"22","author":"Adelstein","year":"2012","journal-title":"Semin Radiat Oncol"},{"key":"key20180107152345_b27-mco-0-0-1226","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/0030-4220(94)90119-8","article-title":"Salivary duct carcinoma. Part I. A clinicopathologic evaluation and DNA image analysis of 13 cases with review of the literature","volume":"78","author":"Barnes","year":"1994","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"key20180107152345_b28-mco-0-0-1226","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/(SICI)1097-0347(199703)19:2<126::AID-HED7>3.0.CO;2-6","article-title":"Salivary duct carcinoma: Clinical characteristics and treatment strategies","volume":"19","author":"Guzzo","year":"1997","journal-title":"Head Neck"},{"key":"key20180107152345_b29-mco-0-0-1226","first-page":"3781","article-title":"Paclitaxel and carboplatin for recurrent salivary gland malignancies","volume":"20","author":"Airoldi","year":"2000","journal-title":"Anticancer Res"},{"key":"key20180107152345_b30-mco-0-0-1226","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1053\/j.seminoncol.2008.03.009","article-title":"Salivary gland malignancies: The role for chemotherapy and molecular targeted agents","volume":"35","author":"Surakanti","year":"2008","journal-title":"Semin Oncol"},{"key":"key20180107152345_b31-mco-0-0-1226","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1200\/JCO.1990.8.6.1056","article-title":"Fluorouracil, doxorubicin, cyclophosphamide, and cisplatin combination chemotherapy in advanced or recurrent salivary gland carcinoma","volume":"8","author":"Dimery","year":"1990","journal-title":"J Clin Oncol"},{"key":"key20180107152345_b32-mco-0-0-1226","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.oraloncology.2012.05.004","article-title":"Systemic therapy in the management of metastatic or advanced salivary gland cancers","volume":"48","author":"Lagha","year":"2012","journal-title":"Oral Oncol"},{"key":"key20180107152345_b33-mco-0-0-1226","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.ejcts.2007.12.057","article-title":"Lung metastasis resection of adenoid cystic carcinoma of salivary glands","volume":"33","author":"Bobbio","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"key":"key20180107152345_b34-mco-0-0-1226","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s10434-999-0572-8","article-title":"Pulmonary metastasectomy for head and neck cancers","volume":"6","author":"Liu","year":"1999","journal-title":"Ann Surg Oncol"},{"key":"key20180107152345_b35-mco-0-0-1226","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1007\/s12032-011-9884-1","article-title":"Targeted therapy with trastuzumab for advanced salivary ductal carcinoma: Case report and literature review","volume":"29","author":"Kaidar-Person","year":"2012","journal-title":"Med Oncol"},{"key":"key20180107152345_b36-mco-0-0-1226","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/hed.20614","article-title":"Salivary duct carcinoma: A clinical and histologic review with implications for trastuzumab therapy","volume":"29","author":"Nabili","year":"2007","journal-title":"Head Neck"},{"key":"key20180107152345_b37-mco-0-0-1226","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/hed.20714","article-title":"Successful treatment of pulmonary metastatic salivary ductal carcinoma with trastuzumab-based therapy","volume":"30","author":"Prat","year":"2008","journal-title":"Head Neck"},{"key":"key20180107152345_b38-mco-0-0-1226","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.humpath.2011.08.006","article-title":"EGFR, HER2, survivin, and loss of pSTAT3 characterize high-grade malignancy in salivary gland cancer with impact on prognosis","volume":"43","author":"Ettl","year":"2012","journal-title":"Hum Pathol"},{"key":"key20180107152345_b39-mco-0-0-1226","first-page":"280","article-title":"Salivary gland tumors: Immunohistochemical study of EGF EGFR, ErbB-2, FAS and Ki-67","volume":"31","author":"Ito","year":"2009","journal-title":"Anal Quant Cytol Histol"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mco.2017.1226\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T19:32:51Z","timestamp":1658950371000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mco.2017.1226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,21]]},"references-count":39,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,4,21]]},"published-print":{"date-parts":[[2017,6]]}},"alternative-id":["10.3892\/mco.2017.1226"],"URL":"https:\/\/doi.org\/10.3892\/mco.2017.1226","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,21]]}}}